Pediatric GVHD Low Risk Steroid Taper Trial

Clinical trial NCT05090384 · COMPLETED

Trial details

NCT number: NCT05090384
Sponsor: John Levine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Graft vs Host Disease Allogeneic Bone Marrow Transplantation Adverse Effects

Start date: 2022-10-20
Primary completion: 2025-03-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.